These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 19204155)

  • 21. Plasma amyloid-β oligomers and soluble tumor necrosis factor receptors as potential biomarkers of AD.
    Zhang J; Peng M; Jia J
    Curr Alzheimer Res; 2014 May; 11(4):325-31. PubMed ID: 24635842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
    Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
    J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ
    An SSA; Lee BS; Yu JS; Lim K; Kim GJ; Lee R; Kim S; Kang S; Park YH; Wang MJ; Yang YS; Youn YC; Kim S
    Alzheimers Res Ther; 2017 Oct; 9(1):86. PubMed ID: 29041968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
    Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T
    Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ELISA measurement of specific non-antigen-bound antibodies to Aβ1-42 monomer and soluble oligomers in sera from Alzheimer's disease, mild cognitively impaired, and noncognitively impaired subjects.
    Klaver AC; Coffey MP; Smith LM; Bennett DA; Finke JM; Dang L; Loeffler DA
    J Neuroinflammation; 2011 Aug; 8():93. PubMed ID: 21827691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma amyloid-β oligomers level is a biomarker for Alzheimer's disease diagnosis.
    Zhou L; Chan KH; Chu LW; Kwan JS; Song YQ; Chen LH; Ho PW; Cheng OY; Ho JW; Lam KS
    Biochem Biophys Res Commun; 2012 Jul; 423(4):697-702. PubMed ID: 22704931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Sensitive and Cost-Effective Chemiluminescence ELISA for Measurement of Amyloid-β 1-42 Peptide in Human Plasma.
    Mehta PD; Patrick BA; Miller DL; Coyle PK; Wisniewski T
    J Alzheimers Dis; 2020; 78(3):1237-1244. PubMed ID: 33252086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Highly specific and ultrasensitive plasma test detects Abeta(1-42) and Abeta(1-40) in Alzheimer's disease.
    Thijssen EH; Verberk IMW; Vanbrabant J; Koelewijn A; Heijst H; Scheltens P; van der Flier W; Vanderstichele H; Stoops E; Teunissen CE
    Sci Rep; 2021 May; 11(1):9736. PubMed ID: 33958661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlations of amyloid-β concentrations between CSF and plasma in acute Alzheimer mouse model.
    Cho SM; Kim HV; Lee S; Kim HY; Kim W; Kim TS; Kim DJ; Kim Y
    Sci Rep; 2014 Oct; 4():6777. PubMed ID: 25345439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of diagnosis, intra- and inter-person variability on serum and plasma Abeta levels.
    Abdullah L; Paris D; Luis C; Quadros A; Parrish J; Valdes L; Keegan AP; Mathura V; Crawford F; Mullan M
    Neurosci Lett; 2007 Nov; 428(2-3):53-8. PubMed ID: 17964720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.
    Li R; Lindholm K; Yang LB; Yue X; Citron M; Yan R; Beach T; Sue L; Sabbagh M; Cai H; Wong P; Price D; Shen Y
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3632-7. PubMed ID: 14978286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma Oligomer β-Amyloid and White Matter Microstructural Integrity in Cognitively Normal Older Adults According to Cerebral Amyloid Deposition.
    Wang SM; Kang DW; Um YH; Kim S; Lee CU; Scheltens P; Lim HK
    J Prev Alzheimers Dis; 2023; 10(4):837-846. PubMed ID: 37874106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A digital enzyme-linked immunosorbent assay for ultrasensitive measurement of amyloid-β 1-42 peptide in human plasma with utility for studies of Alzheimer's disease therapeutics.
    Song L; Lachno DR; Hanlon D; Shepro A; Jeromin A; Gemani D; Talbot JA; Racke MM; Dage JL; Dean RA
    Alzheimers Res Ther; 2016 Dec; 8(1):58. PubMed ID: 27978855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating immune complexes of Abeta and IgM in plasma of patients with Alzheimer's disease.
    Marcello A; Wirths O; Schneider-Axmann T; Degerman-Gunnarsson M; Lannfelt L; Bayer TA
    J Neural Transm (Vienna); 2009 Jul; 116(7):913-20. PubMed ID: 19415450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of Aβ oligomer levels in matched cerebrospinal fluid and serum samples.
    Kasai T; Tokuda T; Taylor M; Kondo M; Mann DM; Foulds PG; Nakagawa M; Allsop D
    Neurosci Lett; 2013 Sep; 551():17-22. PubMed ID: 23811027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No correlation between time-linked plasma and CSF Abeta levels.
    Le Bastard N; Aerts L; Leurs J; Blomme W; De Deyn PP; Engelborghs S
    Neurochem Int; 2009 Dec; 55(8):820-5. PubMed ID: 19695299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Characterization of amyloid beta protein species in the plasma, cerebrospinal fluid and brains of patients with Alzheimer's disease].
    Tamaoka A
    Nihon Ronen Igakkai Zasshi; 1998 Apr; 35(4):273-7. PubMed ID: 9643008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The normal equilibrium between CSF and plasma amyloid beta levels is disrupted in Alzheimer's disease.
    Giedraitis V; Sundelöf J; Irizarry MC; Gårevik N; Hyman BT; Wahlund LO; Ingelsson M; Lannfelt L
    Neurosci Lett; 2007 Nov; 427(3):127-31. PubMed ID: 17936506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer's Disease.
    Williams SM; Schulz P; Rosenberry TL; Caselli RJ; Sierks MR
    J Alzheimers Dis; 2017; 58(1):23-35. PubMed ID: 28372328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.
    Williams SM; Schulz P; Sierks MR
    Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.